This inventor holds 16 USPTO granted patents and 17 published patent applications, plus 1 CIPO patent and 14 EPO patents. Top assignee: Dsm IP Assets B.v.. Active years: 2011-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Pijnacker, NL (2011 - 2022)
- Echt, NL (2017 - 2022)
Company Filing History:
Years Active: 2011-2022
Title: The Innovative Contributions of Johannes Andries Roubos
Introduction
Johannes Andries Roubos, hailing from Echt, Netherlands, is a noteworthy inventor with a remarkable portfolio of 16 patents. His contributions primarily focus on the fields of molecular biology and cell biology, showcasing his commitment to advancing scientific knowledge and technology.
Latest Patents
Among his latest innovations are two significant patents involving the CRISPR-Cas system. The first patent relates to a CRISPR-Cas system tailored for an algal host cell, while the second focuses on a similar system designed for filamentous fungal host cells. Both inventions reflect Roubos' expertise in harnessing cutting-edge genetic engineering techniques to benefit various biological applications.
Career Highlights
Throughout his career, Roubos has made significant strides in the industry by working with esteemed companies such as DSM IP Assets B.V. His affiliation with such organizations has enabled him to refine his inventions and contribute to impactful research and development efforts within the biotechnology sector.
Collaborations
Collaboration is vital in the pursuit of innovation, and Roubos has worked alongside accomplished colleagues, including Bernard Meijrink and René Verwaal. These partnerships have likely enhanced the scope and effectiveness of his research endeavors, fostering an environment of creativity and shared expertise.
Conclusion
Johannes Andries Roubos exemplifies the spirit of innovation through his extensive patent portfolio and collaborative efforts in molecular biology. His latest contributions to CRISPR technology signify a promising direction for future research, potentially leading to groundbreaking developments in both scientific and practical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
